A carregar...

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy

BACKGROUND: Sublingual formulations of buprenorphine (BUP) and BUP/naloxone have well-established pharmacokinetic and pharmacodynamic profiles, and are safe and effective for treating opioid use disorder. Since approvals of these formulations, their clinical use has increased. Yet, questions have ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Alcohol Depend
Main Authors: Greenwald, Mark K., Comer, Sandra D., Fiellin, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4252738/
https://ncbi.nlm.nih.gov/pubmed/25179217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2014.07.035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!